版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
POLITICS
&
SOCIETYLymediseaseintheU.S.CHAPTER
01OverviewNumberofcasesofnotifiablevector-bornediseasesintheU.S.in2021,bydiseaseNumberofcasesofvector-bornediseaseU.S.2021,bydiseaseNumberofreportedcases4,000
6,00002,0008,0008,16210,00012,00014,00016,00018,000Anaplasmosis/Ehrlichiosis(tick-borne)Babesiosis(tick-borne)2,429Chikungunya(mosquito-borne)
35Dengue(mosquito-borne)Easternequineencephalitis(mosquito-borne)Lymedisease(tick-borne)182516,211Malaria(mosquito-borne)1,503Plague(flea-borne)4Powassan(tick-borne)
25SpottedFeverRickettsia(tick-borne)*
43St.Louisencephalitis(mosquito-borne)
17Tularemia(tick-borne)162WestNilevirus(mosquito-borne)2,9063Description:In2021,therewerearound16,211confirmedcasesofLymedisease,makingitthemostcommonvector-bornediseaseintheUnitedStates.Lymediseaseistransmittedtohumansthroughticks.Themostcommonmosquito-bornediseaseintheU.S.atthattimewasWestNilevirus.Thisstatisticdisplaysthenumberofcasesofnotifiablevector-bornediseasesintheU.S.in2021,bydisease.ReadmoreNote(s):UnitedStatesSource(s):CDC(NNDSS)Numberoftick-bornediseasecasesreportedintheU.S.from2004to2022Tick-bornediseasecasesreportedintheU.S.2004-202275,00065,00055,00071,34659,35050,86349,82548,61047,74346,23143,65442,64945,00035,00025,00015,00040,79539,99340,11936,17734,89031,80826,80026,07323,77022,5272004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
20224Description:Thisgraphshowsthetotalnumberoftick-bornediseasecasesreportedintheU.S.from2004to2022.Intheyear2004,therewere22,527reportedtick-bornediseasecases,comparedto2022whentherewere71,346suchcases.
ReadmoreNote(s):UnitedStates;2004to2022Source(s):CDC(NationalCenterforEmergingandZoonoticInfectiousDiseases(NCEZID))Numberoftick-bornediseasecasesreportedintheU.S.from2019to2022,bydiseaseTick-bornediseasecasesreportedintheU.S.2019-2022,bydiseaseNumberofcasesreported2022
2021
2020
201920,000
30,000010,00040,00050,00060,00070,00062,551LymediseaseAnaplasmosis24,61118,01034,9455,6336,7445,6553,6391,271SpottedfeverrickettsiosisEhrlichiachaffeensisehrlichiosisBabesiosis1,2781,1755,2071,5571,3471,1802,0931,9151,8272,418167Tularemia
11560227495Undeterminedehrlichiosis/anaplasmosis
570718547Powassanvirus
22144325Ehrlichiaewingiiehrlichiosis
1921435Description:In2022,therewere62,551reportedcasesofLymediseaseintheUnitedStates,anincreasefrom34,945casesin2019.Thisgraphshowsthenumberoftick-bornediseasecasesreportedintheU.S.from2019to2022,bydisease.
ReadmoreNote(s):UnitedStates;2019to2022Source(s):CDC(NationalCenterforEmergingandZoonoticInfectiousDiseases(NCEZID))Totalvector-bornediseasefundingbytheNationalInstitutesforHealth(NIH)fromFY2015toFY2025(inmillionU.S.dollars)Totalvector-bornediseasefundingbyNationalInstitutesforHealth2015-202590082880070060050040030020010007467437397317306306115575464392015201620172018201920202021202220232024*2025*6Description:Infiscalyear2023,vector-bornediseasefundingbytheNIHwasaround750millionU.S.dollars.Thisgraphshowsthetotalvector-bornediseasefundingbytheNationalInstitutesforHealth(NIH)fromFY2015toFY2023andestimatesforFYs2024and2025.ReadmoreNote(s):UnitedStates;asofMay2024Source(s):NIHTotalLymediseasefundingbytheNationalInstitutesforHealth(NIH)fromFY2015toFY2025(inmillionU.S.dollars)TotalLymediseasefundingbyNationalInstitutesforHealth2015-2025605050434343403940302010032302824222015201620172018201920202021202220232024*2025*7Description:Infiscalyear2025,LymediseasefundingbytheNIHstoodat43millionU.S.dollars.ThisgraphshowsthetotalLymediseasefundingbytheNationalInstitutesforHealth(NIH)fromFY2015toFY2023andestimatesforFYs2024and2025.
ReadmoreNote(s):UnitedStates;asofMay2024Source(s):NIHCHAPTER
02IncidenceandprevalenceConfirmedcasesofLymediseaseintheU.S.from1996to2022U.S.Lymediseasecasesfrom1996to202275,00065,00055,00062,51945,00036,42935,19833,46133,66635,00025,00015,0005,00030,83130,15823,76319,80419,93117,73018,00016,45516,8011996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
20229Description:In2022,therewere62,519confirmedcasesofLymediseaseintheUnitedStates.Lymediseaseisabacterialinfectiontransmittedbytickstohumans.Itisthemostcommonlyreportedvector-borneillnessintheUnitedStates.ThisstatisticdisplaysthenumberofconfirmedLymediseasecasesintheUnitedStatesfrom1996to2022.ReadmoreNote(s):UnitedStates;1996to2022;ConfirmedcasesonlySource(s):CDCIncidenceratesofLymediseaseintheU.S.from1996to2022(per100,000persons)U.S.Lymediseaseincidenceratesfrom1996to2022201816141218.8311.5611.2810.5110.39.759.82108.2686.766.676.286.116.095.4664201996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
202210Description:In2022,theincidencerateofLymediseasewasaround19per100,000population.Lymediseaseisabacterialinfectionspreadbyticks.Itisthemostcommonlyreportedvector-borneillnessintheUnitedStates.ThisstatisticdisplaystheincidenceratesofconfirmedLymediseasecasesintheUnitedStatesfrom1996to2022,per100,000persons.ReadmoreNote(s):UnitedStates;1996to2022;ConfirmedcasesonlySource(s):CDCNumberofLymediseasecasesintheU.S.in2022,bystateU.S.Lymediseasecasesin2022,bystateNumberofcases02,0004,0006,0008,00010,00012,00014,00016,00018,000NewYorkPennsylvaniaNewJerseyWisconsinMassachusettsMinnesotaMaine16,7988,4135,8975,2085,0522,6852,653WestVirginiaRhodeIslandMarylandConnecticutVirginia2,4702,3262,0352,0221,4031,312Vermont11Description:In2022,NewYorkhad16,798casesofLymedisease.Thatyear,therewereatotalof62,519casesofLymediseaseintheUnitedStates.Lymediseaseisabacterialinfectionspreadbyticks.Lymediseaseisthemostcommonlyreportedvector-borneillnessintheUnitedStates.ThisstatisticdisplaysthenumberofconfirmedLymediseasecasesineachstateintheUnitedStatesin2022.ReadmoreNote(s):UnitedStates;2022Source(s):CDCIncidenceratesofLymediseaseintheU.S.in2022,bystate(per100,000persons)U.S.Lymediseaseincidenceratesin2022,bystateCasesper100,000persons100050150200250RhodeIslandVermont212202.8Maine192.6WestVirginiaWisconsin138.388.6NewYork84.6NewHampshireMassachusettsPennsylvaniaNewJerseyConnecticutMinnesotaMaryland78.272.364.763.655.8473312Description:In2022,theU.S.stateswiththehighestratesofLymediseasewereRhodeIsland,Vermont,andMaine.However,thestateswiththehighesttotalnumberofLymediseasecaseswereNewYork,Pennsylvania,andNewJersey.Thatyear,therewereatotalof2,653casesofLymediseaseinthestateofMaine,withanincidencerateof192.6per100,000population.ReadmoreNote(s):UnitedStates;2022Source(s):CDCNumberofLymediseasecasesintheUnitedStatesintheperiod2008-2022,byraceNumberofLymediseasecasesintheU.S.2008-2022,byrace350,000290,007300,000250,000200,000150,000100,00050,0000210,59116,649Other5,054Black4,7471,486WhiteUnknownAsian/PacificIslanderNativeAmerican13Description:Intheperiod2008to2022,therewerearound290thousandLymediseasecasesamongwhitepeopleintheUnitedStates.ThisstatisticshowsthenumberofLymediseasecasesintheUnitedStatesintheperiod2008to2022,byrace
ReadmoreNote(s):NorthAmerica,UnitedStatesSource(s):CDC(NationalCenterforEmergingandZoonoticInfectiousDiseases(NCEZID))PercentageoftotalLymediseasecasesintheUnitedStatesintheperiod2008-2022,byageandgenderShareofLymediseasecasesintheU.S.2008-2022,byageandgenderFemaleMale0.06%4.95%4.85%0.05%0.04%0.03%0.02%0.01%0%4.71%4.61%4.39%3.91%4.23%3.82%3.67%3.52%3.47%3.38%3.31%3.19%2.72%3.05%2.77%2.75%2.29%2.49%2.52%2.08%2.45%1.74%2.29%1.88%2.13%1.89%1.98%1.86%1.64%1.69%1.19%1.13%0.740%.71%0-45-910-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-8485+14Description:Intheperiod2008to2022,malesaged55to59yearsaccountedfor4.85percentofallLymediseasecasesintheUnitedStates.ThisstatisticshowsthepercentageoftotalLymediseasecasesintheUnitedStatesintheperiod2008to2022,byageandgender.ReadmoreNote(s):NorthAmerica,UnitedStatesSource(s):CDC(NationalCenterforEmergingandZoonoticInfectiousDiseases(NCEZID))RateofLymediseaseintheUnitedStatesintheperiod2008-2022,byageandgender(per100,000population)LymediseaseincidenceratesintheU.S.2008-2022,byageandgenderFemaleMale201816141210818.5218.4418.0216.7915.5115.415.4914.1913.7213.6313.4111.8212.8412.6511.411.0410.710.4410.429.889.78.568.458.027.557.227.035.246.576.526.25.975.495.915.7565.034200-45-910-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-8485+15Description:Fromtheperiod2008to2022,theincidencerateofLymediseaseamongmalesintheUnitedStateswashighestamongthoseaged65to69years.ThisstatisticshowstheincidencerateofLymediseaseintheUnitedStatesintheperiod2008to2022,byageandgender.ReadmoreNote(s):NorthAmerica,UnitedStatesSource(s):CDC(NationalCenterforEmergingandZoonoticInfectiousDiseases(NCEZID))NumberofcasesofLymediseaseintheU.S.from2008to2022,bymonth*NumberofLymediseasecasesintheU.S.from2008to2022,bymonthNumberofcases40,000
50,000010,0007,70720,00030,00060,00070,00080,00090,000100,000JanuaryFebruaryMarch6,3128,325April12,604May28,875June84,91887,802JulyAugustSeptemberOctoberNovemberDecember38,14421,57419,01012,0507,03516Description:From2008to2022,therewerearound87,802casesofLymediseasewithanonsetinJuly.Lymediseaseisabacterialinfectiontransmittedbytickstohumans.Itisthemostcommonlyreportedvector-borneillnessintheUnitedStates.ThisstatisticdisplaysthenumberofcasesofLymediseaseintheU.S.from2008to2022,bymonth.ReadmoreNote(s):UnitedStates;2008to2022Source(s):CDCCHAPTER
03EmergencydepartmentvisitsfortickbitesNumberofemergencydepartment(ED)visitsfortickbitesintheUnitedStatesfrom2017to2019,bygenderNumberoftickbitevisitstotheEDintheU.S.from2017to2019,bygenderMaleFemale35,00030,84628,67830,00025,00020,00015,00010,0005,000024,91723,79921,48019,64420172018201918Description:From2017to2019,menweremorelikelythanwomentohavevisitedtheemergencydepartmentduetotickbites.In2019,nearly31thousandmenvisitedtheEDfortickbites,whilenearly24thousandwomendidso.ThisstatisticshowsthenumberofemergencydepartmentvisitsfortickbitesintheUnitedStatesfrom2017to2019,bygender.ReadmoreNote(s):UnitedStates;January2017toDecember2019Source(s):CDC(NationalSyndromicSurveillanceProgram);MMWRIncidenceofemergencydepartment(ED)visitsfortickbitesintheUnitedStatesfrom2017to2019,bygender(per100,000EDvisits)IncidenceoftickbitevisitstotheEDintheU.S.from2017to2019,bygenderTotalMaleFemale8070605040302010072625554494343393420172018201919/statistics/1235949/incidence-tick-bite-ed-visit-by-genderFrom2017to2019,menweremorelikelythanwomentohavevisitedtheemergencydepartmentduetotickbites.ThisstatisticshowstheincidenceofemergencydepartmentvisitsfortickbitesintheUnitedStatesfrom2017to2019,bygender.
ReadmoreNote(s):UnitedStates;January2017toDecember2019Source(s):CDC(NationalSyndromicSurveillanceProgram);MMWRNumberofemergencydepartment(ED)visitsfortickbitesintheUnitedStatesfrom2017to2019,byregionNumberoftickbitevisitstotheEDintheU.S.from2017to2019,byregion20172018201940,00034,67435,00030,00025,00020,00015,00010,0005,000033,26026,0868,7518,2947,8258,0477,7197,0261,810West1,9849348999421,113NortheastMidwestSoutheastSouthCentral20Description:From2017to2019,theNortheastconsistentlyreportedthemostvisitstotheemergencydepartment(ED)duetotickbites.In2019,roughlyevery3in5tickbitevisitstotheEDintheUnitedStateswerereportedfromtheNortheastregion.ThisstatisticshowsthenumberofEDvisitsfortickbitesintheUnitedStatesfrom2017to2019,byregion.ReadmoreNote(s):UnitedStates;January2017toDecember2019Source(s):CDC(NationalSyndromicSurveillanceProgram);MMWRIncidenceofemergencydepartment(ED)visitsfortickbitesintheUnitedStatesfrom2017to2019,byregion(per100,000EDvisits)RateoftickbitevisitstotheEDintheU.S.from2017to2019,byregion2017201820191401201008012811289603935403327262515201414121190NortheastMidwestSoutheastSouthCentralWest21Description:In2019,theNortheastreportedthehighestratesoftickbitevisitstotheemergencydepartment(ED)witharound112tickbitevisitstotheEDper100,000EDvisits.ThisstatisticshowstheincidencerateofEDvisitsfortickbitesintheUnitedStatesfrom2017to2019,byregion.ReadmoreNote(s):UnitedStates;January2017toDecember2019Source(s):CDC(NationalSyndromicSurveillanceProgram);MMWRIncidenceofemergencydepartment(ED)visitsfortickbitesintheUnitedStatesfrom2017to2019,byagegroup(per100,000EDvisits)RateoftickbitevisitstotheEDintheU.S.from2017to2019,byage2017201820191201008060402000-9
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2024年企業(yè)間技術(shù)秘密轉(zhuǎn)讓與保密合同
- 2024《教育基金贈(zèng)與合同》
- 2024年度二手挖掘機(jī)質(zhì)量保證合同
- 2024年奶牛養(yǎng)殖收購(gòu)合同
- 2024年度融資合同融資項(xiàng)目及融資金額
- 2024年建筑工程屋面分包協(xié)議
- 2024年度★店鋪轉(zhuǎn)讓及培訓(xùn)協(xié)議
- 2024年度生物醫(yī)藥實(shí)驗(yàn)室安裝內(nèi)部承包合同
- 2024年企業(yè)間關(guān)于物聯(lián)網(wǎng)技術(shù)研發(fā)與應(yīng)用合作協(xié)議
- 2024供應(yīng)鏈金融借款合同
- 幼兒園中班健康教案《腸胃小鬧鐘》含反思
- 裝配式建筑精裝修裝配施工方法
- GB∕T 24789-2022 用水單位水計(jì)量器具配備和管理通則
- 亞馬遜開店基本操作介紹課件(同名1242)
- 三年級(jí)語文上冊(cè)課件-《15.搭船的鳥》 (共18張PPT)部編版
- 畫法幾何 華中科大-新2-1
- 研學(xué)旅行概論教學(xué)課件匯總完整版電子教案
- NYT 393-綠色食品 農(nóng)藥使用準(zhǔn)則
- TSG Z8001-2019特種設(shè)備無損檢測(cè)人員考核規(guī)則-高清正版
- 人教版八上名著閱讀《昆蟲記》分章練習(xí)(含答案)
- 醫(yī)護(hù)人員服務(wù)禮儀及行為規(guī)范-PPT課件
評(píng)論
0/150
提交評(píng)論